Beverly Welch

1.1k total citations
10 papers, 313 citations indexed

About

Beverly Welch is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Beverly Welch has authored 10 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Beverly Welch's work include Systemic Sclerosis and Related Diseases (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Mast cells and histamine (3 papers). Beverly Welch is often cited by papers focused on Systemic Sclerosis and Related Diseases (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Mast cells and histamine (3 papers). Beverly Welch collaborates with scholars based in United States and Italy. Beverly Welch's co-authors include Ellen Goldmuntz, Ashley Pinckney, James McNamara, Angela Lares, Marc K. Hellerstein, Amy Putnam, Kelly A. Remedios, Mariela Pauli, Michael D. Rosenblum and Maria Dall’Era and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Annals of the Rheumatic Diseases and Arthritis & Rheumatology.

In The Last Decade

Beverly Welch

10 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly Welch United States 8 154 116 106 60 51 10 313
Giuseppe Argentino Italy 9 147 1.0× 46 0.4× 43 0.4× 31 0.5× 100 2.0× 20 335
Valérie Badot Belgium 12 142 0.9× 44 0.4× 104 1.0× 39 0.7× 221 4.3× 26 413
Frances Hall United Kingdom 7 147 1.0× 33 0.3× 100 0.9× 15 0.3× 93 1.8× 15 294
Francisco Javier López-Longo Spain 10 62 0.4× 60 0.5× 87 0.8× 15 0.3× 123 2.4× 15 239
Maresa Carulli United Kingdom 4 146 0.9× 38 0.3× 107 1.0× 54 0.9× 98 1.9× 7 303
C. Frantz France 9 134 0.9× 123 1.1× 266 2.5× 20 0.3× 61 1.2× 18 410
Jeanne Pistillo United States 6 150 1.0× 76 0.7× 118 1.1× 47 0.8× 27 0.5× 12 571
Yunyun Fei China 9 148 1.0× 42 0.4× 31 0.3× 44 0.7× 203 4.0× 14 368
Norio Hanata Japan 9 130 0.8× 53 0.5× 23 0.2× 42 0.7× 93 1.8× 18 255
Olga L. Bohn United States 11 39 0.3× 81 0.7× 65 0.6× 141 2.4× 59 1.2× 18 352

Countries citing papers authored by Beverly Welch

Since Specialization
Citations

This map shows the geographic impact of Beverly Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Welch more than expected).

Fields of papers citing papers by Beverly Welch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Welch. The network helps show where Beverly Welch may publish in the future.

Co-authorship network of co-authors of Beverly Welch

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly Welch. A scholar is included among the top collaborators of Beverly Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly Welch. Beverly Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wareing, Nancy, Xuan Wang, Ellen Goldmuntz, et al.. (2024). Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long‐Term Normalization of Systemic Sclerosis Molecular Signatures. Arthritis & Rheumatology. 76(8). 1288–1293. 3 indexed citations
2.
Ayoglu, Burcu, Michele Donato, Daniel E. Furst, et al.. (2023). Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation. Annals of the Rheumatic Diseases. 82(5). 670–680. 10 indexed citations
3.
Adamska, Julia Z., Amin Zia, Michelle S. Bloom, et al.. (2022). Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 82(3). 357–364. 11 indexed citations
4.
Zamanian, Roham T., David B. Badesch, Leland W.K. Chung, et al.. (2021). Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 204(2). 209–221. 119 indexed citations
5.
Pinckney, Ashley, Ellen Goldmuntz, Beverly Welch, et al.. (2021). Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data. Arthritis Care & Research. 75(2). 307–316. 7 indexed citations
7.
Bellocchi, Chiara, Binwu Ying, Ellen Goldmuntz, et al.. (2020). Large‐Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis. Arthritis & Rheumatology. 73(4). 660–670. 10 indexed citations
8.
Zamanian, Roham T., David B. Badesch, Leland W.K. Chung, et al.. (2019). Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension. RCT1884–RCT1884. 6 indexed citations
9.
Dall’Era, Maria, Mariela Pauli, Kelly A. Remedios, et al.. (2018). Adoptive Treg Cell Therapy in a Patient With Systemic Lupus Erythematosus. Arthritis & Rheumatology. 71(3). 431–440. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026